Results 101 to 110 of about 30,184 (151)

Determinantes sociais da tuberculose

, 2018
Este recurso educacional visa promover a compreensão sobre os determinantes sociais e as populações com maior vulnerabilidade para a tuberculose, como os portadores de HIV, a população privada de liberdade, indivíduos em situação de rua, profissionais da
Universidade Federal do Maranhão - UNA-SUS/UFMA
core  

Role of the IL8 rs4073 polymorphism in central nervous system toxicity in patients receiving multidrug-resistant tuberculosis treatment. [PDF]

J Bras Pneumol
Badamasi IM, Muhammad M, Umar AA, Madugu UM, Gadanya MA, Aliyu IA, Kabir IM, Umar IA, Johnson O, Stanslas J.   +9 more
europepmc   +1 more source

Cutaneous malakoplakia: case report and review. [PDF]

An Bras Dermatol, 2013
Afonso JP, Ando PN, Padilha MH, Michalany NS, Porro AM.   +4 more
europepmc   +1 more source

A population-based tuberculosis contact investigation in the country of Georgia. [PDF]

Public Health Action, 2018
Baliashvili D, Kempker RR, Blumberg HM, Kuchukhidze G, Merabishvili T, Aslanikashvili A, Magee MJ.   +6 more
europepmc   +1 more source

Tratamento da tuberculose

, 2018
Este recurso educacional visa promover a compreensão sobre o tratamento da tuberculose, considerando todos os fatores envolvidos neste processo. Apresenta os princípios do tratamento para a TB e uma linha do tempo evolutiva dos medicamentos para o ...
Universidade Federal do Maranhão - UNA-SUS/UFMA
core  

Screening for tuberculosis and LTBI in diabetes patients, Pohnpei, Federated States of Micronesia. [PDF]

Public Health Action, 2014
Defang RR, Brostrom R, Ram S, Johnson E, Perman PS.   +4 more
europepmc   +1 more source

Guidelines for the pharmacological treatment of COVID-19. The task-force/consensus guideline of the Brazilian Association of Intensive Care Medicine, the Brazilian Society of Infectious Diseases and the Brazilian Society of Pulmonology and Tisiology. [PDF]

Rev Bras Ter Intensiva, 2020
Falavigna M, Colpani V, Stein C, Azevedo LCP, Bagattini AM, Brito GV, Chatkin JM, Cimerman S, Corradi MFDB, Cunha CAD, Medeiros FC, Oliveira Junior HA, Fritscher LG, Gazzana MB, Gräf DD, Marra LP, Matuoka JY, Nunes MS, Pachito DV, Pagano CGM, Parreira PCS, Riera R, Silva A, Tavares BM, Zavascki AP, Rosa RG, Dal-Pizzol F.   +26 more
europepmc   +1 more source

Does antiretroviral treatment increase the infectiousness of smear-positive pulmonary tuberculosis? [PDF]

Int J Tuberc Lung Dis, 2017
Khan PY, Crampin AC, Mzembe T, Koole O, Fielding KL, Kranzer K, Glynn JR.   +6 more
europepmc   +1 more source

Mycobacterium tuberculosis latent infection in healthcare students: systematic review of prevalence. [PDF]

Rev Esc Enferm USP
Lima RS, Silva RND, André SR, Pinheiro AKC, Sousa AI, Silva IFSD, Santos JD, Nogueira LMV, Zeitoune RCG.   +8 more
europepmc   +1 more source

Isoniazid preventive treatment among child contacts of adults with smear-positive tuberculosis in The Gambia. [PDF]

Public Health Action, 2016
Egere U, Sillah A, Togun T, Kandeh S, Cole F, Jallow A, Able-Thomas A, Hoelscher M, Heinrich N, Hill PC, Kampmann B.   +10 more
europepmc   +1 more source